Strong inhibition of xenografted tumor growth by low-level doses of [(32)P]ATP
about
Purinergic signalling and cancerPurinergic signalling in the gastrointestinal tract and related organs in health and diseasePhosphorus-32, a clinically available drug, inhibits cancer growth by inducing DNA double-strand breakageRecent progress in targeting cancer.[32P]ATP inhibits the growth of xenografted tumors in nude mice.Theranostic Role of 32P-ATP as Radiopharmaceutical for the Induction of Massive Cell Death within Avascular Tumor Core.
P2860
Strong inhibition of xenografted tumor growth by low-level doses of [(32)P]ATP
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Strong inhibition of xenografted tumor growth by low-level doses of [(32)P]ATP
@ast
Strong inhibition of xenografted tumor growth by low-level doses of [(32)P]ATP
@en
type
label
Strong inhibition of xenografted tumor growth by low-level doses of [(32)P]ATP
@ast
Strong inhibition of xenografted tumor growth by low-level doses of [(32)P]ATP
@en
prefLabel
Strong inhibition of xenografted tumor growth by low-level doses of [(32)P]ATP
@ast
Strong inhibition of xenografted tumor growth by low-level doses of [(32)P]ATP
@en
P2093
P2860
P356
P1433
P1476
Strong inhibition of xenografted tumor growth by low-level doses of [(32)P]ATP
@en
P2093
Gilbert M Green
John M Abraham
Martin G Pomper
Rachana Agarwal
Ron C Mease
Stephen J Meltzer
Yulan Cheng
P2860
P304
P356
10.18632/ONCOTARGET.289
P407
P577
2011-06-01T00:00:00Z